Peptide Synthesis Market Growth Trajectory Through 2024-2033

The Peptide Synthesis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Peptide Synthesis Market:
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

According to The Business Research Company’s Peptide Synthesis Global Market Report 2024, The peptide synthesis market size has grown strongly in recent years. It will grow from $5.22 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, demand for high-purity peptides, regulatory approvals and standardization..

The peptide synthesis market size is expected to see strong growth in the next few years. It will grow to $8.05 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rapid growth in therapeutic peptides, increasing demand for customized peptides, growing role in drug discovery and development, focus on peptide libraries for screening.. Major trends in the forecast period include development of peptide mimetics, adoption of novel amino acid derivatives, peptide cyclization techniques, innovations in solid-phase peptide synthesis (spps), utilization of click chemistry..

Growing chronic diseases are expected to propel the growth of the peptide synthesis market going forward. Chronic diseases refer to illnesses or non-communicable diseases (NCDs) that are long-term health conditions that persist over an extended period and often progress gradually. Peptide synthesis can be used for chronic diseases as some peptides exert anti-inflammatory and antioxidant activity, which could aid in the prevention of chronic diseases, including cardiovascular diseases. Peptides can address the fundamental causes of chronic disease by targeting particular cellular processes and signaling pathways, opening up novel therapeutic and management options. For instance, in August 2023, according to the data published by the British Heart Foundation, a UK-based non-profit organization, the number of deaths caused by coronary heart disease in the UK increased to 65,579 in 2021, compared with 64,170 in 2020. Therefore, the growing number of chronic diseases is driving the growth of the peptide synthesis market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp

The peptide synthesis market covered in this report is segmented –

1) By Product And Service: Reagents, Equipment, Services
2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes

Major companies operating in the peptide synthesis market are focusing on introducing next-generation peptide synthesizers such as PurePep Sonata+ to gain a competitive edge in the market. PurePep Sonata+ is an advanced peptide synthesizer that offers improved efficiency, speed, and accuracy compared to traditional peptide synthesizers. For instance, in March 2022, Gyros Protein Technologies, a US-based peptide synthesis and bioanalytical technology services company, introduced the PurePep Sonata+ peptide synthesizer. PurePep Sonata+ extends the capabilities of Sonata XT by incorporating real-time flow technology. This innovative approach enables continuous monitoring of fluid flow rates within the system, providing a non-invasive means to ensure precise and accurate fluid transfers for a diverse range of viscosities.

The peptide synthesis market report table of contents includes:

1. Executive Summary
2.Peptide Synthesis Market Characteristics
3. Peptide Synthesis Market Trends And Strategies
4.Peptide Synthesis Market analysis
5.Peptide Synthesis Market Size And Growth
6.Peptide Synthesis Segmentation
7.Peptide Synthesis Regional And Country Analysis
.
.
.
27.Peptide Synthesis Competitive Landscape And Company Profiles
28.Peptide Synthesis Key Mergers And Acquisitions
29.Peptide Synthesis Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Thermo Fisher Scientific
• Novo Nordisk A/S
• Merck KGaA
• Lonza Group
• Kaneka Corporation
• Uno Minda

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model